Age as a predictive factor of disease activity after discontinuation of Disease Modifying Treatment in Multiple Sclerosis

被引：0
|
作者：
Soares, Mafalda Delgado [1 ,2 ]
Faustino, Patricia [1 ,2 ]
Sequeira, Joao [2 ]
Marques, Jose Pinto [2 ]
Sousa, Ana [2 ]
Grine, Teresa [2 ]
Mateus, Claudia [2 ]
Encarnacao, Susana [2 ]
Santos, Ana Catarina [2 ]
Gama, Anabela [2 ]
Capela, Carlos [2 ]
Ladeira, Filipa [2 ]
机构：
[1] Ctr Hosp Univ Lisboa Cent, Neurol, Dept Lisbon, Lisbon, Portugal
[2] Ctr Hosp Univ Lisboa Cent, Multiple Sclerosis Ctr Integrated Responsabil, Lisbon, Portugal
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1521/1363
引用
收藏
页码：970 / 971
页数：2
相关论文
共 50 条
  • [31] No association between disease modifying treatment and fatigue in multiple sclerosis
    Broch, Line
    Flemmen, Heidi Oyen
    Simonsen, Cecilia Smith
    Berg-Hansen, Pal
    Ormstad, Heidi
    Brunborg, Cathrine
    Celius, Elisabeth Gulowsen
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
  • [32] Disease-modifying treatment of secondary progressive multiple sclerosis
    Hoffmann, Olaf
    Gold, Ralf
    NERVENARZT, 2021, 92 (10): : 1052 - 1060
  • [33] Reactivation of disease activity in patients with multiple sclerosis after Natalizumab discontinuation: a case report in Venezuela
    Soto, I
    Ferrer, O.
    Molina, O.
    Mora, E.
    Villalobos, V.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1860 - 1860
  • [34] "Disease modifying nutricals" for multiple sclerosis
    Schmitz, Katja
    Barthelmes, Julia
    Stolz, Leonie
    Beyer, Susanne
    Diehl, Olaf
    Tegeder, Irmgard
    PHARMACOLOGY & THERAPEUTICS, 2015, 148 : 85 - 113
  • [35] Disease modifying therapies in multiple sclerosis
    Sharrack, B.
    Jenkins, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 532 - 534
  • [36] Disease modifying therapies in multiple sclerosis
    Khatri, BO
    McQuillen, MP
    NEUROLOGY, 2002, 59 (03) : 471 - 472
  • [37] Multiple sclerosis disease activity and disability following discontinuation of fingolimod for pregnancy
    Tokic, M.
    Thiel, S.
    Hemat, S.
    Timmesfeld, N.
    Ciplea, A.
    Gold, R.
    Langer-Gould, A.
    Hellwig, K.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 188 - 189
  • [38] Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy
    Hellwig, Kerstin
    Tokic, Marianne
    Thiel, Sandra
    Esters, Nina
    Spicher, Charlotte
    Timmesfeld, Nina
    Ciplea, Andrea, I
    Gold, Ralf
    Langer-Gould, Annette
    JAMA NETWORK OPEN, 2022, 5 (01) : E2144750
  • [39] Patient-reported loneliness and pessimism are associated with EDSS progression after discontinuation of disease modifying therapies in multiple sclerosis
    Vaughn, C.
    Kavak, K.
    Weinstock-Guttman, B.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 145 - 146
  • [40] Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients
    Assunta Bianco
    Matteo Lucchini
    Rocco Totaro
    Roberta Fantozzi
    Giovanna De Luca
    Sonia Di Lemme
    Giorgia Presicce
    Luana Evangelista
    Valeria Di Tommaso
    Roberta Pastorino
    Chiara De Fino
    Valeria De Arcangelis
    Diego Centonze
    Massimiliano Mirabella
    Neurotherapeutics, 2021, 18 : 2598 - 2607
12345